LS, how do you cook/prepare all those Veg that you seem to eat? (or should I ask how your mom cooks them for you?)
Ok, you're just steaming them in their own juices, that works, just don't nuke'em to death. crunchy is best, the reason you are eating them to begin with is their nutrient profile, so don't destroy everything inside
Those steam bags are great, really makes a quick and healthy veggie side dish in no time. I also like to use a basket steamer in a large pot of with a little boiling water but there is more cleanup involved.
that's how i do it.. LIGHTLY steam, but don't let the water touch mostly though, i eat RAW!!!i know that's radical, god forbid
Because of farming methods today in the US, important trace minerals, i.e., Mg, Mn, Mo, Se, Zn, Cu, Chromium are deficient in the soil--and in the plants. In fact, over 70% of the U.S. population is zinc-deficient. GMO vegetables don't have the same vitamin content compared with vegs grown 15-20 years ago. Also, vegetables are a good source of the 8 essential sugars--mannose, galactose, fucose, n-acetyl-glucosamine, etc.--which all increase production of stem cells in the bone marrow--to wher- ever they're needed in the body for repair processes.
Great topic, too bad it got kind of hijacked by AS. I try to be vegetarian myself but people like AS really scare me away from the diet. They are so common in the veg community that I seriously wonder if the behaviour isn't related to some dietary deficiency. Anyway, my 2c is that native societies have developed diets based on the collective experience of millions of people. We can never recreate that knowledge base from limited studies. I say just copy traditional diet using fresh organic food - almost no one does this by the way - it means cutting out sugar, white flour, most vegetable oil, and eating a lot more raw and fermented food.
Don't look back A new day is breakin' It's been too long since I felt this way I don't mind where I get taken The road is callin' Today is the day I can see It took so long just to realize I'm much too strong Not to comprimise Now I see what I am is holding me down I'll turn it around I finally see the dawn arrivin' I see beyond the road I'm drivin' Far away and left behind It's a new horizon and I'm awakin' now Oh I see myself in a brand new way The sun is shinin' the clouds are breakin' 'Canse I can't lose now, there's no game to play I can tell There's no more time left to critize I've seen what I could not recognize Everthing in my life was leading me on but I can be strong I finally see the dawn arrivin' I see beyond the road I'm drivin' Far away and left behind http://youtube.com/watch?v=KiOqHLVxZvA&feature=related eat a carrot dikwad
Remember that article I linked about cholesterol, and how it was unimportant, or nearly so, in the grand scheme of things? Remember how the author said the older statins did reduce heart-related events, but not because they lowered cholesterol, but rather, because they were anti-inflammatory (just like Omega-3, 6, fatty acids)? Just more cannon fodder: Doubt Cast on 2 Drugs Used to Lower Cholesterol By ALEX BERENSON Published: March 31, 2008 http://www.nytimes.com/2008/03/31/business/31drug-web.html?_r=1&oref=slogin CHICAGO â Two widely prescribed cholesterol-lowering drugs, Vytorin and Zetia, may not work and should be used only as a last resort, a panel of four cardiologists told an audience of more than 5,000 people at a major cardiology conference on Sunday. Instead, physicians and patients should rely more heavily on older cholesterol-lowering drugs called statins, which have proven benefits and can be cheaper, the panel said. âThe strongest recommendation we can make on this panel is to go back to statins,â said Dr. Harlan M. Krumholz, a cardiologist at Yale. âThey work.â Statins include drugs like Lipitor and simvastatin, the generic version of Zocor. But other, lesser-known drugs like niacin should also be tried before Vytorin and Zetia, the panel said. Vytorin and Zetia are among the top-selling drugs in the world, with combined sales of $5 billion last year. About five million people worldwide, including four million Americans, take the medicines, which have been heavily advertised to consumers in the United States. The New England Journal of Medicine made a similar recommendation about the drugs in an editorial published on Sunday. Both the panel and the editorial were timed to coincide with the release of full results from a two-year clinical trial that showed that the drugs failed to slow, and might have even sped up, the growth of fatty plaques in the arteries. Growth of those plaques is closely correlated with heart attacks and strokes. Merck and Schering-Plough, the companies that make Vytorin and Zetia, said on Sunday that they disagreed with the recommendations. Vytorin and Zetia have been proved to lower cholesterol and are valuable treatments for patients, said Dr. Rick Veltri, vice president of the Schering-Plough research institute. âWe feel that nothingâs changed,â Dr. Veltri said. The stakes of the debate are high both medically and financially. The drugs produce about 70 percent of Schering-Ploughâs profit, according to analysts. Prescriptions for the medicines have already dipped by about 15 percent since January, when preliminary results were disclosed from the trial discussed in detail on Sunday. Still, the drugs are very widely used, with about three million prescriptions written each month in the United States alone. Unlike statins, which block the liver from making cholesterol, Zetia works by blocking the intestine from absorbing cholesterol in food. Vytorin is a single pill that combines Zetia with simvastatin, or Zocor. LDL cholesterol, the harmful kind, is known as a risk factor for heart disease, and so doctors have generally assumed that lowering LDL cholesterol would reduce the risk of heart attacks and strokes. But proving that a drug actually cuts those risks requires an expensive, multiyear clinical trial involving 10,000 or more patients. Those studies, called outcomes trials, have been conducted for statins, and they have proved that patients taking those drugs do have a reduced risk of heart disease. No such outcomes trials exist for Vytorin and Zetia. The Food and Drug Administration initially approved Zetia in 2002 on the basis of trials that lasted no more than 12 weeks and covered only 3,900 patients. In 2006, four years after Zetia reached the market, Merck and Schering began enrolling patients in their own outcomes study, which compares people taking Vytorin to those taking Zocor alone. But the companies said Friday that the results of the trial, which had been expected in 2011, would not be available until 2012, and possibly later. As a result, doctors who prescribe the medicines are doing so without hard evidence that they help patients, said Dr. Steven Nissen, chairman of cardiology at the Cleveland Clinic. âWeâve got a drug that has no clinical outcome trials,â Dr. Nissen said. âI advise my colleagues essentially to use this drug only as a last resort.â Dr. John Kastelein, the Dutch cardiologist who conducted the trial, called Enhance, that was discussed at the conference, said the companies must aggressively explore reasons that the trial failed. For example, they need to examine closely whether Zetia blocks the absorption of nutrients other than cholesterol in the intestine, or whether it has other effects on the lining of blood vessel walls. âWe can use a lot better science,â he said. The recommendations released Sunday will probably have an immediate impact on clinical practice, said Dr. Douglas Weaver, the incoming president of the American College of Cardiology, which was host of the conference. Nearly half of the 30,000 cardiologists in the United States attend the conference, and many of those doctors heard the panelâs recommendations firsthand. âI do think that the drugs have been overutilized in this country,â Dr. Weaver said. Heavy marketing has probably contributed to that overuse, he added. But use will decline as more patients and doctors focus on the results of the Enhance trial. âSometimes you have to tell people multiple times before they get the message,â he said.